Policy Briefing
TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs?
Government portal promises dramatic discounts, but experts question real-world affordability for insured patients The Trump administration launched TrumpRx.gov on Thursday evening, a government-run portal connecting cash-paying patients with pharmaceutical manufacturers offering discounted prescription drugs. The website went live with 43
6 February 2026